NCT06611384

Brief Summary

Prevalence of Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

September 23, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 25, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

March 10, 2026

Status Verified

March 1, 2026

Enrollment Period

2.5 years

First QC Date

September 23, 2024

Last Update Submit

March 7, 2026

Conditions

Acute Myocardial Infarction

Keywords

Hemorrhagic Myocardial InfarctionCCS-AMI Reperfusion InjuryArrhythmia

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Ventricular Arrhytmia

    Prevalence of Premature Ventricular Contractions (PVCs), Non-Sustained Ventricular Tachycardia (NSVT), and Ventricular Tachycardia/Ventricular Fibrillation (VT/VF) detected by post-PCI Holter monitoring.

    24 hours

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Acute MI with Primary PCI

1. Age 18-85 years 2. Index STEMI 3. Coronary angiogram with Primary coronary intervention 4. No contraindications for Cardiac MRI

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (2)

IU School of Medicine/ IUHealth, Krannert Cardiovascular Research Center

Indianapolis, Indiana, 46202, United States

Location

Synergy Cardiovascular Research Center

Rajkot, India

Location

MeSH Terms

Conditions

Arrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Rohan Dharmakumar, PhD

    Indiana University School of Medicine

    STUDY DIRECTOR

  • Keyur P Vora, MD MS FACC

    Indiana University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Executive Director, Medical Imaging Research Institute

Study Record Dates

First Submitted

September 23, 2024

First Posted

September 25, 2024

Study Start

June 1, 2022

Primary Completion

December 10, 2024

Study Completion

March 30, 2025

Last Updated

March 10, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations

IN(1)US(1)